Skip to content

Study of brain multilevel excitation/inhibition imbalance network model in the schizophrenia and bipolar disorder

Study of brain multilevel excitation/inhibition imbalance network model in the schizophrenia and bipolar disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102292
Enrollment
Unknown
Registered
2025-05-13
Start date
2025-05-15
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia and bipolar disorder

Interventions

Healthy control group:None
Schizophrenia group:None

Sponsors

Hangzhou Seventh People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria for the disease group: 1. The discharge diagnosis of inpatients was adopted, which met the diagnostic criteria for schizophrenia or bipolar disorder in ICD-10; 2. Age: 18-55 years old 3. Education: Primary school graduation or above, capable of understanding the content of neuropsychological tests; 4. Race: Han ethnicity 5. Voluntarily participate in this study and sign the informed consent form. 2.Inclusion criteria for healthy controls: 1. Interviews were conducted with normal controls to rule out any disease or disorder in the diagnostic criteria of ICD-10; 2. Good social function (able to go to work or school normally, not retiring due to illness), with full behavioral and responsibility capabilities; 3. Age: 18-55 years old; 4. Education: Primary school graduation or above, capable of understanding the content of neuropsychological tests; 5. Race: Han ethnicity 6. Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Exclusion criteria for the disease group: 1. Those with severe physical diseases, organic brain diseases, or neurological diseases; 2. Individuals with other mental disorders such as depression, obsessive-compulsive disorder, schizoid affective mental disorder, organic mental disorder, and material-related mental disorder, as well as other cognitive disorders such as mental retardation, who meet the criteria of ICD-10; 3. Those with color blindness or color weakness that affects neurocognitive tests, or those with metal objects in their bodies (such as metal dentures, pacemakers, etc.) that affect MRI examinations. 2.Exclusion criteria for the healthy control group: 1. Disease history: Individuals with mental disorders or personality disorders diagnosed by ICD-10; Those with serious physical diseases, organic brain diseases or neurological diseases; 2. Family history: Those with a positive family history of mental illness in the second and third generations; 3. History of drug treatment: Those who have taken antipsychotic drugs, antidepressants, or used benzodiazepines or other drugs affecting the central nervous system one month before MRI and cognitive examinations; 4. Those with color blindness or color weakness that affects neurocognitive tests, or those with metal objects in their bodies (such as metal dentures, pacemakers, etc.) that affect MRI examinations.

Design outcomes

Primary

MeasureTime frame
Positive And Negative Syndrome Scale;

Secondary

MeasureTime frame
Hamilton Anxiety Rating Scale;P300 electroencephalogram;Young Manic Rating Scale;The Mood Disorder Scale;Inflammatory factor;Generalized Anxiety Disorder;Selected Items from the Symptom Checklist 90 (SCL-90);Sheehan Disability Scale;Personal and Social Performance scale;Perceived Deficit Questionnaire for Depression;ASSR electroencephalogram;Resting-state electroencephalogram;Hamilton Depression Rating Scale;MMN electroencephalogram;

Countries

China

Contacts

Public ContactXue Rui

Hangzhou Seventh People's Hospital

xuerui8686@163.com+86 138 8067 8696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026